2016 Hematological Malignancies

GHSG Risk Allocation for HL Patients

Stage (Ann Arbor)

Risk factors

IA, IB, IIA

IIB

IIIA, IIIB

IVA, IVB

Early favorable

None

≥3 LN areas

Advanced

Elevated ESR

Early unfavorable

Large med mass

Extranodal disease

Made with